Search research articles
Contact Us
Filters
Showing results (71-80 of 94) with videos related to
Page
of 10
Sort By:
Journal of Clinical Lipidology
|
June 30, 2022
Benefits of icosapent ethyl for enhancing residual cardiovascular risk reduction: A review of key findings from REDUCE-IT
Prakriti Gaba, Deepak L Bhatt, R Preston Mason, et al.
Journal of the American College of Cardiology
|
March 22, 2008
Circulating lipid hydroperoxides predict cardiovascular events in patients with stable coronary artery disease: the PREVENT study
Mary F Walter, Robert F Jacob, Rebekah E Bjork, et al.
Journal of Atherosclerosis and Thrombosis
|
June 15, 2011
Effect of enhanced glycemic control with saxagliptin on endothelial nitric oxide release and CD40 levels in obese rats
R Preston Mason, Robert F Jacob, Ruslan Kubant, et al.
Journal of the American College of Cardiology
|
November 16, 2004
Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease: a longitudinal analysis of the PREVENT study
Mary F Walter, Robert F Jacob, Barrett Jeffers, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
September 25, 2004
Influence of serum cholesterol on atherogenesis and intimal hyperplasia after angioplasty: inhibition by amlodipine
Mark B Kahn, Kathleen Boesze-Battaglia, David W Stepp, et al.
Journal of Lipid Research
|
April 23, 2004
Direct perturbation of lens membrane structure may contribute to cataracts caused by U18666A, an oxidosqualene cyclase inhibitor
Richard J Cenedella, Robert Jacob, Douglas Borchman, et al.
Journal of Cardiovascular Pharmacology
|
June 21, 2006
Rofecoxib increases susceptibility of human LDL and membrane lipids to oxidative damage: a mechanism of cardiotoxicity
R Preston Mason, Mary F Walter, Hyesun P McNulty, et al.
Pharmaceutical Research
|
December 19, 2007
Synergistic effect of amlodipine and atorvastatin in reversing LDL-induced endothelial dysfunction
R Preston Mason, Ruslan Kubant, Gehan Heeba, et al.
Journal of Lipid Research
|
November 1, 2005
A membrane defect in the pathogenesis of the Smith-Lemli-Opitz syndrome
Thomas N Tulenko, Kathy Boeze-Battaglia, R Preston Mason, et al.
American Journal of Hypertension
|
September 5, 2009
Loss of arterial and renal nitric oxide bioavailability in hypertensive rats with diabetes: effect of beta-blockers
R Preston Mason, Ruslan Kubant, Robert F Jacob, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 94) with videos related to
Sort By:
Page
of 10
Journal of Clinical Lipidology
|
June 30, 2022
Benefits of icosapent ethyl for enhancing residual cardiovascular risk reduction: A review of key findings from REDUCE-IT
Prakriti Gaba, Deepak L Bhatt, R Preston Mason, et al.
Journal of the American College of Cardiology
|
March 22, 2008
Circulating lipid hydroperoxides predict cardiovascular events in patients with stable coronary artery disease: the PREVENT study
Mary F Walter, Robert F Jacob, Rebekah E Bjork, et al.
Journal of Atherosclerosis and Thrombosis
|
June 15, 2011
Effect of enhanced glycemic control with saxagliptin on endothelial nitric oxide release and CD40 levels in obese rats
R Preston Mason, Robert F Jacob, Ruslan Kubant, et al.
Journal of the American College of Cardiology
|
November 16, 2004
Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease: a longitudinal analysis of the PREVENT study
Mary F Walter, Robert F Jacob, Barrett Jeffers, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
September 25, 2004
Influence of serum cholesterol on atherogenesis and intimal hyperplasia after angioplasty: inhibition by amlodipine
Mark B Kahn, Kathleen Boesze-Battaglia, David W Stepp, et al.
Journal of Lipid Research
|
April 23, 2004
Direct perturbation of lens membrane structure may contribute to cataracts caused by U18666A, an oxidosqualene cyclase inhibitor
Richard J Cenedella, Robert Jacob, Douglas Borchman, et al.
Journal of Cardiovascular Pharmacology
|
June 21, 2006
Rofecoxib increases susceptibility of human LDL and membrane lipids to oxidative damage: a mechanism of cardiotoxicity
R Preston Mason, Mary F Walter, Hyesun P McNulty, et al.
Pharmaceutical Research
|
December 19, 2007
Synergistic effect of amlodipine and atorvastatin in reversing LDL-induced endothelial dysfunction
R Preston Mason, Ruslan Kubant, Gehan Heeba, et al.
Journal of Lipid Research
|
November 1, 2005
A membrane defect in the pathogenesis of the Smith-Lemli-Opitz syndrome
Thomas N Tulenko, Kathy Boeze-Battaglia, R Preston Mason, et al.
American Journal of Hypertension
|
September 5, 2009
Loss of arterial and renal nitric oxide bioavailability in hypertensive rats with diabetes: effect of beta-blockers
R Preston Mason, Ruslan Kubant, Robert F Jacob, et al.
Page
of 10